Journal rankings · indicator year 2018
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2018
Oncology journal rankings 2018
224 ranked journals · Subfield in Medicine
Oncology has 224 ranked journals in 2018. The median journal has an OJR of 0.82, below the world average of 1.00, down 0.02 on 2017; Q1 starts at OJR 1.33. The top three are CA A Cancer Journal for Clinicians, Nature Medicine, and The Lancet Oncology.
Ranks and citation indicators: 2018. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2015–2017, the window the 2018 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery901
- Pulmonary and Respiratory Medicine349
- Public Health, Environmental and Occupational Health289
- Cardiology and Cardiovascular Medicine280
- Oncology224
- Infectious Diseases210
- Epidemiology193
- Endocrinology, Diabetes and Metabolism162
- Neurology161
- Physiology155
- Radiology, Nuclear Medicine and Imaging146
- Psychiatry and Mental health141
Show all 42 subfields
- Orthopedics and Sports Medicine115
- Pediatrics, Perinatology and Child Health101
- Ophthalmology95
- Dermatology89
- Hematology78
- Obstetrics and Gynecology73
- Rheumatology65
- Nephrology59
- Complementary and alternative medicine54
- Pharmacology51
- Reproductive Medicine50
- Emergency Medicine42
- Geriatrics and Gerontology34
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine30
- Hepatology24
- Critical Care and Intensive Care Medicine23
- Immunology and Allergy21
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology15
- Gastroenterology7
- Internal Medicine4
- Transplantation3
- Family Practice2
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
224 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2017. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2015–2017, the window the 2018 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2015–2017 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2009 to 2018. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 87.61Q1 | 240.26 21.50 down from 2017 | 83 | 100% | $4,330 | ||
2Nature MedicineNature Portfolio · United States | 8.67Q1 | 21.22 1.43 down from 2017 | 788 | 56% | $12,690 | ||
3The Lancet OncologyElsevier BV · United Kingdom | 7.33Q1 | 18.71 0.52 up from 2017 | 1,158 | 28% | $7,280 | ||
4Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 6.57Q1 | 15.91 0.43 down from 2017 | 1,933 | 4% | — | ||
5Cancer CellCell Press · Netherlands | 6.00Q1 | 17.31 1.19 up from 2017 | 551 | 99% | $10,400 | ||
6Breast CareKarger Publishers · Switzerland | 5.77Q1 | 21.84 1.43 down from 2017 | 222 | 81% | — | ||
7JAMA OncologyAmerican Medical Association · United States | 3.92Q1 | 9.37 1.02 up from 2017 | 1,097 | 53% | — | ||
8Annals of OncologyElsevier BV · Netherlands | 3.68Q1 | 9.48 0.89 down from 2017 | 1,414 | 100% | $5,080 | ||
9Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 3.39Q1 | 8.98 1.57 up from 2017 | 426 | 92% | — | ||
10Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.28Q1 | 9.43 0.34 up from 2017 | 2,107 | 37% | — | ||
11Seminars in Cancer BiologyElsevier BV · United States | 3.03Q1 | 8.16 1.78 down from 2017 | 259 | 30% | $6,060 | ||
12Cancer Immunology ResearchAmerican Association for Cancer Research · United States | 3.02Q1 | 9.12 0.74 down from 2017 | 362 | 36% | — | ||
13JNCI Journal of the National Cancer InstituteOxford University Press · United States | 2.99Q1 | 8.41 0.04 up from 2017 | 691 | 87% | $5,436 | ||
14European Journal of EpidemiologySpringer Science+Business Media · Italy | 2.92Q1 | 6.86 0.05 up from 2017 | 342 | 65% | $3,690 | ||
15Journal of Hematology & OncologyOABioMed Central · United Kingdom | 2.91Q1 | 9.65 1.57 up from 2017 | 430 | 100% | $4,990 | ||
16Therapeutic Advances in Medical OncologyOASAGE Publishing · United Kingdom | 2.70Q1 | 6.21 0.29 down from 2017 | 119 | 100% | $2,800 | ||
17ImmunoTargets and TherapyOADove Medical Press · New Zealand | 2.68Q1 | 7.94 1.98 up from 2017 | 32 | 100% | $2,320 | ||
18Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.64Q1 | 10.11 0.70 up from 2017 | 349 | 31% | $4,910 | ||
19npj Precision OncologyOANature Portfolio · United Kingdom | 2.60Q1 | 7.18no 2017 value | 39 | 100% | $4,090 | — | |
20Journal for ImmunoTherapy of CancerOABMJ · United Kingdom | 2.46Q1 | 8.99 2.12 up from 2017 | 291 | 100% | $2,490 | ||
21CancersOAMultidisciplinary Digital Publishing Institute · Switzerland | 2.41Q1 | 7.69 1.49 up from 2017 | 416 | 100% | $3,499 | ||
22CancerWiley · United States | 2.38Q1 | 5.63 0.15 up from 2017 | 1,684 | 87% | $4,790 | ||
23Cancer DiscoveryAmerican Association for Cancer Research · United States | 2.37Q1 | 6.93 0.07 up from 2017 | 999 | 23% | — | ||
24British Journal of CancerSpringer Nature · United Kingdom | 2.25Q1 | 6.05 0.57 down from 2017 | 1,277 | 99% | $5,190 | ||
25Breast Cancer ResearchOABioMed Central · United Kingdom | 2.18Q1 | 6.63 0.43 down from 2017 | 407 | 100% | $4,190 | ||
26Clinical Pharmacology & TherapeuticsWiley · United States | 2.17Q1 | 4.52 0.59 down from 2017 | 716 | 48% | $4,410 | ||
27npj Breast CancerOANature Portfolio · United States | 2.08Q1 | 7.32 2.19 up from 2017 | 87 | 100% | $3,790 | ||
28Oncology ReviewsOAPAGEPress (Italy) · Switzerland | 2.05Q1 | 6.16 2.91 up from 2017 | 32 | 100% | $2,353 | ||
29Nature Reviews Clinical OncologyNature Portfolio · United Kingdom | 2.03Q1 | 9.40 2.23 up from 2017 | 622 | 13% | — | ||
30Cancer Biology and MedicineOAChinese Anti-Cancer Association · China | 2.00Q1 | 5.44 1.17 up from 2017 | 88 | 100% | $1,500 | ||
31Frontiers in OncologyOAFrontiers Media · Switzerland | 2.00Q1 | 4.96 0.36 down from 2017 | 862 | 100% | $3,801 | ||
32The OncologistOAAlphaMed Press · United Kingdom | 2.00Q1 | 5.24 0.32 down from 2017 | 692 | 100% | $3,852 | ||
33Clinical and Translational GastroenterologyOALippincott Williams & Wilkins · United States | 1.99Q1 | 5.26 0.61 up from 2017 | 197 | 100% | $2,800 | ||
34Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.95Q1 | 4.74 0.09 up from 2017 | 193 | 20% | $4,890 | ||
35Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.90Q1 | 5.15 1.18 up from 2017 | 596 | 100% | — | ||
36Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 1.85Q1 | 5.41 0.06 up from 2017 | 836 | 20% | — | ||
37Current Oncology ReportsSpringer Science+Business Media · United States | 1.84Q1 | 4.81 0.86 up from 2017 | 216 | 18% | $5,090 | ||
38International Journal of CancerWiley · United States | 1.82Q1 | 5.20 0.31 up from 2017 | 1,534 | 87% | $5,030 | ||
39Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 1.80Q1 | 4.38 0.56 down from 2017 | 675 | 35% | — | ||
40Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.75Q1 | 6.25 0.66 up from 2017 | 552 | 21% | $4,190 | ||
41Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.67Q1 | 3.62 0.50 down from 2017 | 217 | 16% | $3,950 | ||
42Seminars in OncologyElsevier BV · United States | 1.66Q1 | 3.56 1.79 down from 2017 | 214 | 30% | $3,550 | ||
43ESMO OpenOAElsevier BV · Netherlands | 1.66Q1 | 4.36 0.67 up from 2017 | 179 | 100% | $3,910 | ||
44Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.58Q1 | 5.34 0.83 up from 2017 | 433 | 99% | $4,590 | ||
45The Journal of Pathology Clinical ResearchOAWiley · United Kingdom | 1.54Q1 | 4.02 0.63 down from 2017 | 70 | 100% | $3,250 | ||
46OncoImmunologyOALandes Bioscience · United States | 1.54Q1 | 5.20 0.47 up from 2017 | 1,170 | 100% | $2,913 | ||
47Clinical Medicine Insights OncologyOASAGE Publishing · United Kingdom | 1.53Q1 | 4.68 0.70 up from 2017 | 57 | 100% | $2,650 | ||
48Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.50Q1 | 4.20 0.52 up from 2017 | 367 | 14% | — | ||
49JMIR CancerOAJMIR Publications · Canada | 1.48Q1 | 4.46 1.49 up from 2017 | 48 | 100% | $1,873 | ||
50Journal of Cancer SurvivorshipSpringer Science+Business Media · United States | 1.46Q1 | 4.38 0.17 down from 2017 | 238 | 53% | $4,790 |
Subfields of Medicine, with Oncology highlighted.
- Surgery901
- Pulmonary and Respiratory Medicine349
- Public Health, Environmental and Occupational Health289
- Cardiology and Cardiovascular Medicine280
- Oncology224
- Infectious Diseases210
- Epidemiology193
- Endocrinology, Diabetes and Metabolism162
- Neurology161
- Physiology155
- Radiology, Nuclear Medicine and Imaging146
- Psychiatry and Mental health141
- Orthopedics and Sports Medicine115
- Pediatrics, Perinatology and Child Health101
- Ophthalmology95
- Dermatology89
- Hematology78
- Obstetrics and Gynecology73
- Rheumatology65
- Nephrology59
- Complementary and alternative medicine54
- Pharmacology51
- Reproductive Medicine50
- Emergency Medicine42
- Geriatrics and Gerontology34
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine30
- Hepatology24
- Critical Care and Intensive Care Medicine23
- Immunology and Allergy21
- Genetics20
- Anesthesiology and Pain Medicine15
- Urology15
- Gastroenterology7
- Internal Medicine4
- Transplantation3
- Family Practice2
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2018. Corpus-wide, 81.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
76 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2015–2017, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2018. Publication window: 2015–2017. How these summaries are calculated
- Ranked journals
- 224
- Window papers (baseline)
- 109,984 +11.5% from indicator year 2015
- Median OJR
- 0.82 -15.1% from indicator year 2015
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2015–2017 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.